Month: April 2021

Apr 16 2021

Uncategorized

Genetic predisposition to schizophrenia may increase risk of psychosis from cannabis use

by Clinical Editor

No Comments

New research shows that while cannabis users had higher rates of psychotic experiences than non-users across the board, the difference was especially pronounced among those with high genetic …

Apr 16 2021

Uncategorized

Genetic predisposition to schizophrenia may increase risk of psychosis from cannabis use

by Clinical Editor

No Comments

New research shows that while cannabis users had higher rates of psychotic experiences than non-users across the board, the difference was especially pronounced among those with high genetic predisposition to...

Apr 15 2021

Uncategorized

Cognitive Behavioral Therapy for Schizophrenia – Healthline

by Clinical Editor

No Comments

Cognitive Behavioral Therapy for Schizophrenia  Healthline

Apr 15 2021

Uncategorized

Genetic predisposition to schizophrenia may increase risk of psychosis from cannabis use

by Clinical Editor

No Comments

It has been long been known that cannabis users develop psychosis more often than non-users, but what is still not fully clear is whether cannabis actually causes psychosis and, if...

Apr 15 2021

Uncategorized

The 6 Best Online Schizophrenia Support Groups of 2021

by Clinical Editor

No Comments

Schizophrenia affects around 3.5 million people in the United States, with the majority of patients being diagnosed in their late teens and early 20s. Common symptoms of the chronic psychiatric...

Apr 15 2021

Uncategorized

Attractor cortical neurodynamics, schizophrenia, and depression

by Clinical Editor

No Comments

A computational neuroscience approach to the stability of attractor networks in the cortex is described, and then it is shown how differences in the operation of these systems are related...

Apr 15 2021

Uncategorized

Schizophrenia Market 2021 Growth Probability, Key Vendors and Future Scenario (PDF Report)|Johnson & Johnson Services, Dainippon Sumitomo Pharma Co

by Clinical Editor

No Comments

The studies on worldwide Schizophrenia market evaluate the capabilities, organizations, infrastructure, determines measures to attain success. Due to an in-depth view of the worldwide Schizophrenia …

Apr 15 2021

Uncategorized

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

by Clinical Editor

No Comments

Clinically stable, overweight (body mass index (BMI) > 25) patients (ages 17–45) within 5 years of a DSM-5 diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder, or under the age...

Apr 14 2021

Uncategorized

Genetic predisposition to schizophrenia may increase risk of psychosis from cannabis use – EurekAlert

by Clinical Editor

No Comments

Genetic predisposition to schizophrenia may increase risk of psychosis from cannabis use  EurekAlert

Apr 14 2021

Uncategorized

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

by Clinical Editor

No Comments

Clinically stable, overweight (body mass index (BMI) > 25) patients (ages 17–45) within 5 years of a DSM-5 diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder, or under the age...